Viscosupplementation for the treatment of osteoarthritis of the knee

Dagenais P, Framarin A
Record ID 32007000425
Authors' objectives:

This report examines the use of viscosupplementation for the treatment of osteoarthritis of the knee.

Authors' recommendations: AETMIS considers that, given the modest effectiveness of this therapeutic treatment compared with placebo, its relatively high cost and the additional professional health resources required to administer it, it is not currently justifi ed to contemplate public funding for viscosupplementation for patients with knee OA in Quebec. However, this treatment could be offered to some people, who would meet strict eligibility criteria similar to those adopted by other third-party payers presented in this report.
Authors' methods: Review
Project Status: Completed
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Osteoarthritis, Knee
Organisation Name: Agence d'évaluation des technologies et des modes d'intervention en santé
Contact Address: 2021, avenue Union, Bureau 10.083,Montreal, Quebec H3A S29, Canada.Tel: +1 514 873 2563; Fax: +1 514 873 1369
Contact Name:
Contact Email:
Copyright: Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.